Literature DB >> 14728989

Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients.

Peter Schadewaldt1, Loganathan Kamalanathan, Hans Werner Hammen, Udo Wendel.   

Abstract

The age dependence of endogenous galactose formation was investigated in Q188R homozygous galactosemic patients (n=18; 4-38 years) using the primed continuous infusion approach with D-[1-13C]galactose as a substrate. Studies were conducted under postabsorptive conditions (fasting >10h) and good metabolic control. In the patients, the release of galactose from endogenous sources into plasma (R(a)) decreased with age and ranged from 4.6 to 2.0 micromol/kg body weight per h. Galactitol and galactonate release rates paralleled the galactose R(a) but at a lower level. The mean relation of galactose, galactitol, and galactonate release was 10:5:1. Statistically, there was a highly significant (p<0.0001) inverse correlation between total galactose release (i.e., sum of R(a) plus galactitol and galactonate release) and age. The data (total galactose=y, age=t) were best fitted to the simple exponential model y=y(0)+axexp(-bt) by non-linear regression analysis. The parameter estimates were y(0)=3.0+/-0.2, a=6.5+/-0.4, and b=0.11+/-0.02. The value of y(0) provides an estimate of total galactose release in adult patients (i.e., approximately 13 mg/kg body weight per day), summation operator (y(0)+a) provides an estimate for galactosemic newborns (i.e., approximately 41 mg/kg body weight per day). The data show that significant amounts of endogenous galactose are formed in galactosemic patients with release rates being several fold higher in infants than in adults. The present findings can explain the persistently elevated galactose-1-phosphate levels in erythrocytes-and its age dependence-in galactosemic patients even when under strict dietary treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14728989     DOI: 10.1016/j.ymgme.2003.10.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  17 in total

1.  Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia.

Authors:  Gerard T Berry; Louis J Elsas
Journal:  J Inherit Metab Dis       Date:  2010-11-30       Impact factor: 4.982

Review 2.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

Review 3.  Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management.

Authors:  Suzanne W Boyer; Lisa J Barclay; Lindsay C Burrage
Journal:  Nutr Clin Pract       Date:  2015-06-16       Impact factor: 3.080

4.  Komrower lecture: Treatment of inborn errors of metabolism: a review.

Authors:  J V Leonard
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 5.  Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.

Authors:  Mortada H F El-Shabrawi; Naglaa M Kamal
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

Review 6.  Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?

Authors:  Gerard T Berry
Journal:  J Inherit Metab Dis       Date:  2011-01-19       Impact factor: 4.982

7.  Renal excretion of galactose and galactitol in patients with classical galactosaemia, obligate heterozygous parents and healthy subjects.

Authors:  P Schadewaldt; S Killius; L Kamalanathan; H W Hammen; K Strassburger; U Wendel
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Biochemical monitoring of pregnancy and breast feeding in five patients with classical galactosaemia--and review of the literature.

Authors:  Peter Schadewaldt; Hans-Werner Hammen; Loganathan Kamalanathan; Udo Wendel; Martin Schwarz; Annet M Bosch; Nele Guion; Mirian Janssen; Godfried H J Boers
Journal:  Eur J Pediatr       Date:  2008-09-24       Impact factor: 3.183

9.  Effects of temporary low-dose galactose supplements in children aged 5-12 y with classical galactosemia: a pilot study.

Authors:  Ina Knerr; Karen Patricia Coss; Jürgen Kratzsch; Ellen Crushell; Anne Clark; Peter Doran; Yoon Shin; Henning Stöckmann; Pauline Mary Rudd; Eileen Treacy
Journal:  Pediatr Res       Date:  2015-06-08       Impact factor: 3.756

Review 10.  Genetics of primary ovarian insufficiency: new developments and opportunities.

Authors:  Yingying Qin; Xue Jiao; Joe Leigh Simpson; Zi-Jiang Chen
Journal:  Hum Reprod Update       Date:  2015-08-04       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.